The inflammatory response and tissue damage View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1987-12

AUTHORS

M. P. Glauser, P. Meylan, J. Bille

ABSTRACT

Most clinical and experimental evidence suggests that renal scarring occurs following urinary tract infections in those patients with an abnormality of the urinary tract or kidney function. Experimentally, bacterial multiplication within the kidney occurs only in the presence of obstruction, leading rapidly to acute exudative pyelonephritis and invariably to kidney scars within weeks. Various manipulations of the bacterial load and/or of the inflammatory response during acute pyelonephritis have demonstrated that the inflammatory processes, not the bacterial component of pyelonephritis, are responsible for permanent renal tissue damage. Polymorphonuclear leucocytes (PMNLs) infiltrating the kidney tissue during acute pyelonephritis appear to release metabolites that are toxic to the parenchyma. Indeed, both the prevention of PMNL influx into renal tissue, by means of colchicine or cyclophosphamide, and the inactivation of some of their toxic metabolites, by means of dapsone, have led to the prevention of tissue damage and kidney scars. However, the most potent protective activity was observed with early antibiotic treatment, which stopped bacterial multiplication and prevented the early influx of PMNLs, thus preventing tissue damage and scar formation. Similar observations have been made in children with acute pyelonephritic episodes, in whom early and aggressive antibiotic treatment prevented subsequent kidney scars, while delayed treatment did not. More... »

PAGES

615-622

References to SciGraph publications

  • 1961-01. The role of endotoxin in autoimmune processes in THE SCIENCE OF NATURE
  • 1985-12. Role of Tamm-Horsfall protein in the pathogenesis of reflux nephropathy and chronic pyelonephritis in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 1974-12. Experimental lipid A-induced nephritis in the dog in INFECTION
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf00853599

    DOI

    http://dx.doi.org/10.1007/bf00853599

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1042329658

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/3153342


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cicatrix", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nephritis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Urinary Tract Infections", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.8515.9", 
              "name": [
                "Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Glauser", 
            "givenName": "M. P.", 
            "id": "sg:person.013633405224.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013633405224.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.8515.9", 
              "name": [
                "Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Meylan", 
            "givenName": "P.", 
            "id": "sg:person.01336350503.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336350503.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.8515.9", 
              "name": [
                "Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bille", 
            "givenName": "J.", 
            "id": "sg:person.0633046707.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633046707.09"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf00589724", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037960774", 
              "https://doi.org/10.1007/bf00589724"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01641456", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023435544", 
              "https://doi.org/10.1007/bf01641456"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02013390", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026532463", 
              "https://doi.org/10.1007/bf02013390"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1987-12", 
        "datePublishedReg": "1987-12-01", 
        "description": "Most clinical and experimental evidence suggests that renal scarring occurs following urinary tract infections in those patients with an abnormality of the urinary tract or kidney function. Experimentally, bacterial multiplication within the kidney occurs only in the presence of obstruction, leading rapidly to acute exudative pyelonephritis and invariably to kidney scars within weeks. Various manipulations of the bacterial load and/or of the inflammatory response during acute pyelonephritis have demonstrated that the inflammatory processes, not the bacterial component of pyelonephritis, are responsible for permanent renal tissue damage. Polymorphonuclear leucocytes (PMNLs) infiltrating the kidney tissue during acute pyelonephritis appear to release metabolites that are toxic to the parenchyma. Indeed, both the prevention of PMNL influx into renal tissue, by means of colchicine or cyclophosphamide, and the inactivation of some of their toxic metabolites, by means of dapsone, have led to the prevention of tissue damage and kidney scars. However, the most potent protective activity was observed with early antibiotic treatment, which stopped bacterial multiplication and prevented the early influx of PMNLs, thus preventing tissue damage and scar formation. Similar observations have been made in children with acute pyelonephritic episodes, in whom early and aggressive antibiotic treatment prevented subsequent kidney scars, while delayed treatment did not.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf00853599", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1097267", 
            "issn": [
              "0931-041X", 
              "1432-198X"
            ], 
            "name": "Pediatric Nephrology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "1"
          }
        ], 
        "keywords": [
          "tissue damage", 
          "polymorphonuclear leucocytes", 
          "kidney scars", 
          "acute pyelonephritis", 
          "antibiotic treatment", 
          "inflammatory response", 
          "early antibiotic treatment", 
          "aggressive antibiotic treatment", 
          "urinary tract infection", 
          "renal tissue damage", 
          "potent protective activity", 
          "pyelonephritic episodes", 
          "renal scarring", 
          "tract infections", 
          "kidney function", 
          "urinary tract", 
          "inflammatory process", 
          "renal tissue", 
          "presence of obstruction", 
          "pyelonephritis", 
          "scar formation", 
          "early influx", 
          "bacterial multiplication", 
          "kidney tissue", 
          "protective activity", 
          "bacterial load", 
          "bacterial components", 
          "toxic metabolites", 
          "scar", 
          "treatment", 
          "prevention", 
          "tissue", 
          "damage", 
          "metabolites", 
          "cyclophosphamide", 
          "patients", 
          "scarring", 
          "obstruction", 
          "dapsone", 
          "Similar observations", 
          "infection", 
          "kidney", 
          "abnormalities", 
          "leucocytes", 
          "parenchyma", 
          "tract", 
          "weeks", 
          "response", 
          "episodes", 
          "children", 
          "colchicine", 
          "means of colchicine", 
          "influx", 
          "evidence", 
          "inactivation", 
          "experimental evidence", 
          "activity", 
          "presence", 
          "function", 
          "means", 
          "manipulation", 
          "observations", 
          "components", 
          "formation", 
          "multiplication", 
          "load", 
          "process"
        ], 
        "name": "The inflammatory response and tissue damage", 
        "pagination": "615-622", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1042329658"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf00853599"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "3153342"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf00853599", 
          "https://app.dimensions.ai/details/publication/pub.1042329658"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:46", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_215.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf00853599"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00853599'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00853599'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00853599'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00853599'


     

    This table displays all metadata directly associated to this object as RDF triples.

    170 TRIPLES      21 PREDICATES      100 URIs      89 LITERALS      11 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf00853599 schema:about N228c9cd738c94fb096e700d3cbc836d9
    2 Na4d825ee582e409195dd38120c93b191
    3 Nb23f40994fc94d819c2ce0d9a9e11676
    4 Ne9094f17cdda4101918fd03b4927fa08
    5 anzsrc-for:11
    6 anzsrc-for:1103
    7 schema:author N17fa2b8ba20c4eb0846ba78e9262695e
    8 schema:citation sg:pub.10.1007/bf00589724
    9 sg:pub.10.1007/bf01641456
    10 sg:pub.10.1007/bf02013390
    11 schema:datePublished 1987-12
    12 schema:datePublishedReg 1987-12-01
    13 schema:description Most clinical and experimental evidence suggests that renal scarring occurs following urinary tract infections in those patients with an abnormality of the urinary tract or kidney function. Experimentally, bacterial multiplication within the kidney occurs only in the presence of obstruction, leading rapidly to acute exudative pyelonephritis and invariably to kidney scars within weeks. Various manipulations of the bacterial load and/or of the inflammatory response during acute pyelonephritis have demonstrated that the inflammatory processes, not the bacterial component of pyelonephritis, are responsible for permanent renal tissue damage. Polymorphonuclear leucocytes (PMNLs) infiltrating the kidney tissue during acute pyelonephritis appear to release metabolites that are toxic to the parenchyma. Indeed, both the prevention of PMNL influx into renal tissue, by means of colchicine or cyclophosphamide, and the inactivation of some of their toxic metabolites, by means of dapsone, have led to the prevention of tissue damage and kidney scars. However, the most potent protective activity was observed with early antibiotic treatment, which stopped bacterial multiplication and prevented the early influx of PMNLs, thus preventing tissue damage and scar formation. Similar observations have been made in children with acute pyelonephritic episodes, in whom early and aggressive antibiotic treatment prevented subsequent kidney scars, while delayed treatment did not.
    14 schema:genre article
    15 schema:isAccessibleForFree false
    16 schema:isPartOf N44ec13c9dbc242cdbfa67d39fea6510d
    17 Nd8e42e8fd95b442c87e929279e2deba5
    18 sg:journal.1097267
    19 schema:keywords Similar observations
    20 abnormalities
    21 activity
    22 acute pyelonephritis
    23 aggressive antibiotic treatment
    24 antibiotic treatment
    25 bacterial components
    26 bacterial load
    27 bacterial multiplication
    28 children
    29 colchicine
    30 components
    31 cyclophosphamide
    32 damage
    33 dapsone
    34 early antibiotic treatment
    35 early influx
    36 episodes
    37 evidence
    38 experimental evidence
    39 formation
    40 function
    41 inactivation
    42 infection
    43 inflammatory process
    44 inflammatory response
    45 influx
    46 kidney
    47 kidney function
    48 kidney scars
    49 kidney tissue
    50 leucocytes
    51 load
    52 manipulation
    53 means
    54 means of colchicine
    55 metabolites
    56 multiplication
    57 observations
    58 obstruction
    59 parenchyma
    60 patients
    61 polymorphonuclear leucocytes
    62 potent protective activity
    63 presence
    64 presence of obstruction
    65 prevention
    66 process
    67 protective activity
    68 pyelonephritic episodes
    69 pyelonephritis
    70 renal scarring
    71 renal tissue
    72 renal tissue damage
    73 response
    74 scar
    75 scar formation
    76 scarring
    77 tissue
    78 tissue damage
    79 toxic metabolites
    80 tract
    81 tract infections
    82 treatment
    83 urinary tract
    84 urinary tract infection
    85 weeks
    86 schema:name The inflammatory response and tissue damage
    87 schema:pagination 615-622
    88 schema:productId N4a8569d209c449ce99f88df6c6cdf253
    89 N56cc57cb7a014a569ed80252cd753b86
    90 N66ee6a40dda64854a89383aff9f7aaec
    91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042329658
    92 https://doi.org/10.1007/bf00853599
    93 schema:sdDatePublished 2022-11-24T20:46
    94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    95 schema:sdPublisher N88f1b2df07e14ef58021c3e585b8d1b3
    96 schema:url https://doi.org/10.1007/bf00853599
    97 sgo:license sg:explorer/license/
    98 sgo:sdDataset articles
    99 rdf:type schema:ScholarlyArticle
    100 N17fa2b8ba20c4eb0846ba78e9262695e rdf:first sg:person.013633405224.09
    101 rdf:rest N7d9fbde62dcf41e49b121b535929997e
    102 N228c9cd738c94fb096e700d3cbc836d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Urinary Tract Infections
    104 rdf:type schema:DefinedTerm
    105 N44ec13c9dbc242cdbfa67d39fea6510d schema:issueNumber 4
    106 rdf:type schema:PublicationIssue
    107 N4a8569d209c449ce99f88df6c6cdf253 schema:name doi
    108 schema:value 10.1007/bf00853599
    109 rdf:type schema:PropertyValue
    110 N56cc57cb7a014a569ed80252cd753b86 schema:name pubmed_id
    111 schema:value 3153342
    112 rdf:type schema:PropertyValue
    113 N66ee6a40dda64854a89383aff9f7aaec schema:name dimensions_id
    114 schema:value pub.1042329658
    115 rdf:type schema:PropertyValue
    116 N7d9fbde62dcf41e49b121b535929997e rdf:first sg:person.01336350503.09
    117 rdf:rest Nb4858050e9da49d990a5047882799983
    118 N88f1b2df07e14ef58021c3e585b8d1b3 schema:name Springer Nature - SN SciGraph project
    119 rdf:type schema:Organization
    120 Na4d825ee582e409195dd38120c93b191 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Humans
    122 rdf:type schema:DefinedTerm
    123 Nb23f40994fc94d819c2ce0d9a9e11676 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Cicatrix
    125 rdf:type schema:DefinedTerm
    126 Nb4858050e9da49d990a5047882799983 rdf:first sg:person.0633046707.09
    127 rdf:rest rdf:nil
    128 Nd8e42e8fd95b442c87e929279e2deba5 schema:volumeNumber 1
    129 rdf:type schema:PublicationVolume
    130 Ne9094f17cdda4101918fd03b4927fa08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Nephritis
    132 rdf:type schema:DefinedTerm
    133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    134 schema:name Medical and Health Sciences
    135 rdf:type schema:DefinedTerm
    136 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    137 schema:name Clinical Sciences
    138 rdf:type schema:DefinedTerm
    139 sg:journal.1097267 schema:issn 0931-041X
    140 1432-198X
    141 schema:name Pediatric Nephrology
    142 schema:publisher Springer Nature
    143 rdf:type schema:Periodical
    144 sg:person.01336350503.09 schema:affiliation grid-institutes:grid.8515.9
    145 schema:familyName Meylan
    146 schema:givenName P.
    147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336350503.09
    148 rdf:type schema:Person
    149 sg:person.013633405224.09 schema:affiliation grid-institutes:grid.8515.9
    150 schema:familyName Glauser
    151 schema:givenName M. P.
    152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013633405224.09
    153 rdf:type schema:Person
    154 sg:person.0633046707.09 schema:affiliation grid-institutes:grid.8515.9
    155 schema:familyName Bille
    156 schema:givenName J.
    157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633046707.09
    158 rdf:type schema:Person
    159 sg:pub.10.1007/bf00589724 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037960774
    160 https://doi.org/10.1007/bf00589724
    161 rdf:type schema:CreativeWork
    162 sg:pub.10.1007/bf01641456 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023435544
    163 https://doi.org/10.1007/bf01641456
    164 rdf:type schema:CreativeWork
    165 sg:pub.10.1007/bf02013390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026532463
    166 https://doi.org/10.1007/bf02013390
    167 rdf:type schema:CreativeWork
    168 grid-institutes:grid.8515.9 schema:alternateName Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland
    169 schema:name Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland
    170 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...